Recently, somatic mutations in the SH2 dimerization and activation domain of STAT3 were discovered in 40% of patients with large granular lymphocytic leukemia, and these mutations were associated with enhanced phosphorylation of STAT3 and its localization in the nucleus [31]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.